Cipemastat
From Wikipedia, the free encyclopedia
| Cipemastat | |
|---|---|
 |
|
| Identifiers | |
| CAS number | [] |
| PubChem | |
| Properties | |
| Molecular formula | C22H36N4O5 |
| Molar mass | 436.545 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
Cipemastat (rINN, also known as Ro 32-3555 and by the tentative trade name Trocade) is a selective inhibitor of matrix metalloproteinase-1 that has been investigated as an anti-arthritis agent.[1] It is being developed by Roche.
[edit] References
- ^ Hemmings F, Farhan M, Rowland J, Banken L, Jain R (2001). "Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis". Rheumatology (Oxford) 40 (5): 537-43. PMID 11371662.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
